Concepedia

Niva Shraga‐Heled

NS

6

Publications

741

Citations

6

H-Index

2004

Active since

Affiliations

Rappaport Family Institute for Research in the Medical Sciences(Current)

Technion – Israel Institute of Technology

Pluristem Therapeutics (Israel)

Niva Shraga‐Heled is an author at Rappaport Family Institute for Research in the Medical Sciences specializing in oxidative stress, vascular biology, and extracellular matrix.

Top concepts

Publications per year

2004–2018

6

Publications

6

Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis

Ofra Kessler, Niva Shraga‐Heled, Tali Lange et al. · Cancer Research · 2004 · 225 citations

Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis

Noga Guttmann‐Raviv, Niva Shraga‐Heled, Asya Varshavsky et al. · Journal of Biological Chemistry · 2007 · 222 citations · Full text

, , +20

Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1

Claudia Prahst, Mélanie Héroult, Anthony A. Lanahan et al. · Journal of Biological Chemistry · 2008 · 128 citations · Full text

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Oshra Betzer, Rinat Meir, Tamar Dreifuss et al. · Scientific Reports · 2015 · 79 citations · Full text

Neuropilin‐1 and neuropilin‐2 enhance VEGF <sub>121</sub> stimulated signal transduction by the VEGFR‐2 receptor

Niva Shraga‐Heled, Ofra Kessler, Claudia Prahst et al. · The FASEB Journal · 2006 · 66 citations

Rows per page

1–5 of 6